Acta Neurologica Scandinavica

Cover image for Acta Neurologica Scandinavica

December 2000

Volume 102, Issue Supplement s176

Pages 5–99

  1. Preface

    1. Top of page
    2. Preface
    3. Original Articles
    1. Preface (page 5)

      Article first published online: 9 OCT 2008 | DOI: 10.1034/j.1600-0404.2000.102s176005.x

  2. Original Articles

    1. Top of page
    2. Preface
    3. Original Articles
    1. Mutation of conserved aspartates affect maturation of presenilin 1 and presenilin 2 complexes (pages 6–11)

      G. Yu, F. Chen, M. Nishimura, H. Steiner, A. Tandon, T. Kawarai, S. Arawaka, A. Supala, Y-Q. Song, E. Rogaeva, E. Holmes, D. M. Zhang, P. Milman, P. Fraser, C. Haass and P. St George-Hyslop

      Article first published online: 2 JAN 2002 | DOI: 10.1034/j.1600-0404.2000.00301.x

    2. A pharmacogenomic approach to Alzheimer’s disease (pages 12–19)

      R. Cacabelos, A. Alvarez, L. Fenández-Novoa and V. R. M. Lombardi

      Article first published online: 2 JAN 2002 | DOI: 10.1034/j.1600-0404.2000.00302.x

    3. Magnetic resonance spectroscopy in Alzheimer's disease: focus on N-acetylaspartate (pages 20–26)

      J. G. Chen, H. C. Charles, D. Barboriak and P. M. Doraiswamy

      Article first published online: 2 JAN 2002 | DOI: 10.1034/j.1600-0404.2000.00303.x

    4. Ligands for in vivo imaging of nicotinic receptor subtypes in Alzheimer brain (pages 27–33)

      W. Sihver, B. Långström and A. Nordberg

      Article first published online: 2 JAN 2002 | DOI: 10.1034/j.1600-0404.2000.00304.x

    5. Nicotinic receptors in dementia of Alzheimer, Lewy body and vascular types (pages 34–41)

      C. Martin-Ruiz, J. Court, M. Lee, M. Piggott, M. Johnson, C. Ballard, R. Kalaria, R. Perry and E. Perry

      Article first published online: 2 JAN 2002 | DOI: 10.1034/j.1600-0404.2000.00305.x

    6. Classical Alzheimer features and cholinergic dysfunction: towards a unifying hypothesis? (pages 42–48)

      A. Wevers, B. Witter, N. Moser, L. Burghaus, C. Banerjee, O. K. Steinlein, U. Schütz, R. A. I. De Vos, E. N. H. Jansen Steur, J. Lindstrom and H. Schröder

      Article first published online: 2 JAN 2002 | DOI: 10.1034/j.1600-0404.2000.00306.x

    7. Acetylcholinesterase–amyloid-β-peptide interaction and Wnt signaling involvement in Aβ neurotoxicity (pages 53–59)

      N. C. Inestrosa, A. Alvarez, J. Godoy, A. Reyes and G. V. De Ferrari

      Article first published online: 2 JAN 2002 | DOI: 10.1034/j.1600-0404.2000.00308.x

    8. Cholinesterase inhibitors, β-amyloid precursor protein and amyloid β-peptides in Alzheimer's disease (pages 60–67)

      D. K. Lahiri, M. R. Farlow, N. Hintz, T. Utsuki and N. H. Greig

      Article first published online: 2 JAN 2002 | DOI: 10.1034/j.1600-0404.2000.00309.x

    9. Galantamine is an allosterically potentiating ligand of the human α4/β2 nAChR (pages 68–73)

      M. Samochocki, M. Zerlin, R. Jostock, P. J. Groot Kormelink, W.H. M. L. Luyten, E. X. Albuquerque and A. Maelicke

      Article first published online: 2 JAN 2002 | DOI: 10.1034/j.1600-0404.2000.00310.x

    10. The experimental Alzheimer drug phenserine: preclinical pharmacokinetics and pharmacodynamics (pages 74–84)

      N. H. Greig, 1 E. De Micheli, 1 H. W. Holloway, 1 Q.-S. Yu, 1 T. Utsuki, 1 T. A. Perry, 1 D. K. Ingram, 1 J. Deutsch, 2 D. Lahiri and 3 T. T. Soncrant 4

      Article first published online: 2 JAN 2002 | DOI: 10.1034/j.1600-0404.2000.00311.x

    11. Immediate causes of death of demented and non-demented elderly (pages 96–99)

      S. Kammoun, G. Gold, C. Bouras, P. Giannakopoulos, W. McGee, F. Herrmann and J-P. Michel

      Article first published online: 2 JAN 2002 | DOI: 10.1034/j.1600-0404.2000.00314.x

SEARCH

SEARCH BY CITATION